Govt to aid development of India's 1st indigenous thrombectomy device for stroke care
New Delhi: In a significant boost to India's medtech innovation landscape, the Technology Development Board (TDB), under the Union Department of Science and Technology (DST), on Friday announced financial support to the development of India's first indigenous thrombectomy device for stroke care.
The board sanctioned assistance to Mysuru-based S3V Vascular Technologies' pioneering neuro-intervention integrated manufacturing plant for the treatment of stroke, which sees nearly 1.5 million cases every year in the country.
The project envisions the establishment of a state-of-the-art upstream integrated manufacturing facility at the Medical Devices Park, Oragadam in Chennai's Sriperumbudur.
The plant will develop and manufacture advanced mechanical thrombectomy kits -- a life-saving intervention for patients suffering from acute ischemic stroke due to large vessel occlusion.
Compared to conventional thrombolysis, thrombectomy offers significantly improved outcomes, reducing the risk of long-term paralysis and disability.
"The TDB is proud to support S3V's vision of building India's first comprehensive neuro-intervention manufacturing ecosystem. This project reflects our continued commitment to making India a global hub for affordable, high-end medical technology -- especially in areas of critical public health needs like stroke care," TDB Secretary Rajesh Kumar Pathak said.
"The company's focus on integrating these devices into Ayushman Bharat further aligns with the national goal of inclusive healthcare access," he added.
The initiative will help replace expensive imported devices with high-quality, locally manufactured alternatives, enhancing both the affordability and accessibility of stroke care in India.
"Our integrated manufacturing facility will not only reduce dependency on imports of the finished medical devices used in Mechanical Thrombectomy but also reduces India's dependency on import of the raw materials used in manufacturing of these critical complex lifesaving medical devices," S3V Vascular Technologies Managing Director, Dr N.G. Vijaya Gopal, said, while lauding the government for its support.
Gopal said the company has already initiated the CE and the US FDA approval process for the devices to expand access to cutting-edge stroke care solutions across India, Asia, Latin America, Europe, and the US.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
100 days of Rekha Gupta government: Promises, progress, and persistent problems in Delhi
WHAT'S REALISED In first 100 days, the new government in Delhi has made significant strides in fulfilling the BJP's poll promises. Through initiatives in healthcare, education, women's welfare, infrastructure, and environmental sustainability, her administration claims to have laid a strong foundation for the city's development. One of the Gupta's earliest actions was approval of the Ayushman Bharat scheme in Delhi, one that provides health insurance coverage of Rs 5 lakh per family, with an additional Rs 5 lakh top-up funded by the city government. The scheme aims to enhance access to quality healthcare for residents, addressing a long-standing gap in the city's health insurance coverage. The Chief Minister presented a Rs 1 lakh crore budget for 2025-26, marking the highest allocation in the city's history. Notably, Rs 9,000 crore has been allocated for clean drinking water and sanitation projects, and Rs 6,874 crore for health initiatives, including the establishment of new health and wellness centers and the expansion of the Ayushman Arogya Mandir initiative. On May 29, Gupta inaugurated three state-of-the-art health facilities at Lok Nayak Hospital. These include a Medical Genetics Ward, a Lactation Management Unit, and a Nucleic Acid Amplification Testing lab. The Medical Genetics Department is the first of its kind in Delhi government hospitals, focusing on diagnosing and treating rare genetic disorders. The government has prioritised women's welfare in form of the Mahila Samridhi Yojana, allocating Rs 5,100 crore to provide Rs 2,500 per month to eligible women. Additionally, 50,000 CCTV cameras are being installed across Delhi to enhance women's safety. The government has also launched 100 'Atal Canteens' with a budget of Rs 100 crore to ensure food security for the poor. In line with the National Education Policy, the government has announced new CM Shri schools, with an initial Rs 100 crore allocation. Additionally, 175 new computer labs are being established, and smart classes are being installed with a Rs 100 crore budget. Free laptops will be provided to 1,200 students on passing class 10, with Rs 750 crore allocated for this initiative. A new project, 'NEEV – New Era of Entrepreneur Ecosystem and Vision,' has been launched with an allocation of Rs 20 crore to equip children with essential skills for modern economies. The administration has also focused on enhancing the Delhi infrastructure. A Rs 1,000 crore allocation has been made for improved connectivity in the National Capital Region. Additionally, Rs 3,843 crore has been allocated for road and bridge infrastructure, and Rs 696 crore for development in slum clusters. The government is also working on repairing old sewer lines and converting the Haryana-Delhi canal into a pipeline to improve water supply. The BJP government touts its plans of cleaning the Yamuna River by decentralising 40 sewage treatment plants and ensuring that only treated water reaches the river. A Rs 500 crore allocation has been made for this initiative. Additionally, Rs 250 crore has been allocated for repairing old sewer lines, and Rs 50 crore for rainwater harvesting initiatives. The government is also seeking an additional Rs 2,000 crore from the Centre to make water and sewage infrastructure world-class. The Chief Minister has emphasised transparency and public engagement through regular 'Jan Sunwai' (public grievance) sessions held both at the Chief Minister's camp office and in all districts. These sessions aim to strengthen public engagement and address citizens' concerns promptly.
Time of India
an hour ago
- Time of India
Sanofi buys US biopharma group Blueprint in $9.1 billion deal
French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation , a biopharmaceutical company specializing in systemic mastocytosis, a rare immunological disease, the companies said on Monday. Under the terms of the acquisition, Sanofi will pay $129.00 per share in cash, representing an equity value of approximately $9.1 billion. The acquisition "represents a strategic step forward in our rare and immunology portfolios. It enhances our pipeline and accelerates our transformation into the world's leading immunology company," said Sanofi CEO Paul Hudson. The deal will add to Sanofi's portfolio the rare immunology disease drug Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline . Blueprint's established presence among allergists, dermatologists, and immunologists is also expected to enhance Sanofi's growing immunology pipeline, the companies said. Live Events Ayvakit/Ayvakyt is the only approved medicine for advanced and indolent systemic mastocytosis, a rare immunology disease, which is characterized by the accumulation and activation of aberrant mast cells in bone marrow, skin, the gastrointestinal tract, and other organs. The acquisition will also bring elenestinib, a next-generation medicine for systemic mastocytosis, as well as BLU-808, a highly selective and potent oral wild-type KIT inhibitor that has the potential to treat a broad range of diseases in immunology. Besides $129.00 per share in cash at the closing of the deal, Blueprint shareholders will also receive one non-tradeable contingent value right (CVR) which will entitle the holder to receive two potential milestone payments of $2 and $4 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. The total equity value of the transaction, including potential CVR payments, represents approximately $9.5 billion on a fully diluted basis. Hudson said the deal complements recent acquisitions of other early-stage medicines that remain Sanofi's main field of interest and added that Sanofi still retains a sizeable capacity for further acquisitions.
Time of India
4 hours ago
- Time of India
UAE Health Ministry ends birth and death certification service: What you need to know
In a sweeping administrative change, the UAE Ministry of Health and Prevention (MoHAP) has officially ended its role in issuing birth and death certificates. These vital registration services are now handled by Emirates Health Services (EHS) in the northern emirates, while Dubai and Abu Dhabi continue under their respective local health authorities. Tired of too many ads? go ad free now The transition was made quietly, with MoHAP removing all related service options from its website and discontinuing its WhatsApp-based application system. Residents are now required to navigate a decentralised process based on their emirate of residence. What Has Changed? MoHAP has withdrawn from issuing birth and death certificates. Emirates Health Services (EHS) is now responsible in Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah. Dubai Health Authority (DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally. (DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally. Certificates issued by EHS, DHA, or DoH are fully equivalent to those formerly issued by MoHAP. BIRTH CERTIFICATES: How It Works Now Who Can Apply? Parents (of any nationality), legal guardians, or authorised delegates. Where to Apply? Via the EHS website (requires UAE Pass) Through the Mabrouk Ma Yak platform (for Emiratis only) At EHS public health centres or hospitals Documents Needed: Valid Emirates ID and passport for both parents Hospital-issued, certified birth notification Electronic civil record Marriage certificate or notarised parentage document For UAE citizens with births abroad: Return tickets ID and passports of both parents Attested marriage certificate For complex cases (e.g., prison births): Court-issued documents Letters from correctional facilities or social services Birth notifications Fees & Turnaround (Converted to INR) Birth Certificate in Arabic: AED 65 (~₹1,470) English Copy (optional): AED 65 (~₹1,470) Time to Issue: 1 working day DEATH CERTIFICATES: Procedure and Conditions Who Can Apply? Immediate family members or legally authorised persons. Where to Apply? Through the EHS online portal At a designated public health centre or hospital Documents Required: Emirates ID or passport of the deceased No Objection Certificate (NOC) from Ministry of Interior Official death report In suspicious or unknown-cause deaths: Forensic report Name consistency across all documents is mandatory International Use: Certificates must be attested by the UAE Ministry of Foreign Affairs and International Cooperation and the embassy of the relevant foreign country. Fees & Timelines (Converted to INR) Death Certificate in Arabic: AED 65 (~₹1,470) English Copy (optional): AED 65 (~₹1,470) Time to Issue: 5 minutes for e-certificates Physical copy available upon in-person visit Service Hours Monday to Thursday: 7:30 AM to 3:30 PM Friday: 7:30 AM to 12:00 PM Why the Change Matters The UAE is continuing its trend of devolving administrative authority to regional bodies, particularly for citizen services. Emirates Health Services already manages most public healthcare in the northern emirates, making it a natural successor to MoHAP in handling life-event documentation. The Bottom Line The next time you need a birth or death certificate in the UAE, MoHAP is no longer your go-to authority. Depending on where you live, you'll be interacting with EHS, DHA, or DoH—with new procedures, slightly altered fees, and a greater push toward digital verification. While the transition might be procedural, it signals a larger shift in how civil documentation is administered across the UAE—more digital, more localised, and firmly tied to regional health systems. (Exchange rate used: 1 AED = ₹22.60)
